SEB Asset Management AB »

Soleno Therapeutics shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.3M 188k 33.48

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Wellington Management Company
Vanguard Group
venBio Select Advisor
State Street Corporation
Nantahala Capital Management
Vanguard Capital Management
Khrom Capital Management
Geode Capital Management
Polar Capital Holdings
Woodline Partners
Deep Track Capital
Braidwell

View all funds holding Soleno Therapeutics